Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists
Since the discovery of the endomorphins (EM), the postulated endogenous peptide agonists of the mu-opioid receptors, several analogues have been synthesized to improve their binding and pharmacological profiles. We have shown previously that a new analogue, cis-1S,2R-aminocyclohexanecarboxylic acid(...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Hindawi Publishing Corporation
2013
|
| Sorozat: | BIOMED RESEARCH INTERNATIONAL
2013 |
| doi: | 10.1155/2013/501086 |
| mtmt: | 2486869 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/11855 |
| LEADER | 02699nab a2200349 i 4500 | ||
|---|---|---|---|
| 001 | publ11855 | ||
| 005 | 20200221131105.0 | ||
| 008 | 170829s2013 hu o 0|| zxx d | ||
| 022 | |a 2314-6133 | ||
| 024 | 7 | |a 10.1155/2013/501086 |2 doi | |
| 024 | 7 | |a 2486869 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Murányi Marianna | |
| 245 | 1 | 0 | |a Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists |h [elektronikus dokumentum] / |c Murányi Marianna |
| 260 | |a Hindawi Publishing Corporation |c 2013 | ||
| 300 | |a [Terjedelem: 9 p.]-[Azonosító: 501086] | ||
| 490 | 0 | |a BIOMED RESEARCH INTERNATIONAL |v 2013 | |
| 520 | 3 | |a Since the discovery of the endomorphins (EM), the postulated endogenous peptide agonists of the mu-opioid receptors, several analogues have been synthesized to improve their binding and pharmacological profiles. We have shown previously that a new analogue, cis-1S,2R-aminocyclohexanecarboxylic acid(2)-endomorphin-2 (ACHC-EM2), had elevated mu-receptor affinity, selectivity, and proteolytic stability over the parent compound. In the present work, we have studied its antinociceptive effects and receptor regulatory processes. ACHC-EM2 displayed a somewhat higher (60%) acute antinociceptive response than the parent peptide, EM2 (45%), which peaked at 10 min after intracerebroventricular (icv) administration in the rat tail-flick test. Analgesic tolerance developed to the antinociceptive effect of ACHC-EM2 upon its repeated icv injection that was complete by a 10-day treatment. This was accompanied by attenuated coupling of mu-sites to G-proteins in subcellular fractions of rat brain. Also, the density of mu-receptors was upregulated by about 40% in the light membrane fraction, with no detectable changes in surface binding. Distinct receptor regulatory processes were noted in subcellular fractions of rat brains made tolerant by the prototypic full mu-agonist peptide, DAMGO, and its chloromethyl ketone derivative, DAMCK. These results are discussed in light of the recently discovered phenomenon, that is, the "so-called biased agonism" or "functional selectivity". | |
| 700 | 0 | 1 | |a Cinar Resat |e aut |
| 700 | 0 | 1 | |a Kékesi Orsolya Sára |e aut |
| 700 | 0 | 1 | |a Birkás Erika |e aut |
| 700 | 0 | 1 | |a Fábián Gabriella |e aut |
| 700 | 0 | 1 | |a Bozó Bea |e aut |
| 700 | 0 | 1 | |a Zentai András |e aut |
| 700 | 0 | 1 | |a Tóth Géza |e aut |
| 700 | 0 | 1 | |a Kicsi Emese |e aut |
| 700 | 0 | 1 | |a Mácsai Mónika |e aut |
| 700 | 0 | 1 | |a Dochnal Roberta |e aut |
| 700 | 0 | 1 | |a Szabó Gyula |e aut |
| 700 | 0 | 1 | |a Szűcs Mária |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/11855/1/Muranyi_2013.pdf |z Dokumentum-elérés |